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determine whether risk indicators performed
differently in the 2 settings, a term for site and a term
for the interaction of site and the indicator variable
were included in each regression. Indicators with
significant bivariate associations with IPV exposure
were entered into a multiple logistic regression. The
positive and negative predictive values, sensitivity,
specificity and efficiency of the risk indicators in
predicting abuse status were also calculated.
Logistic regression was used to determine the
relationship between the number of positive risk
indicators and IPV status, as well as for combinations
(interactions) of indicators specified a priori to be
strongly associated with IPV status. These
combinations, based on the literature, were as follows:
partner alcohol problem plus partner
underemployment; partner drug problem plus partner
underemployment; and partner drug problem plus
partner alcohol problem.
Results
Descriptive data. Of the 798 eligible women who
entered the 2 EDs during the study period, 768
provided informed consent, for a refusal rate of 3.8%.
Table 1 presents the demographic characteristics of the
768 women in the sample, overall and by site.
Examination of demographic characteristics
indicated some differences between sites. Women in
the larger, urban ED were younger and less likely to be
married. They were also more likely to self-identify as
being a member of a minority group and to have been
born outside Canada. Women in the more urban site
were also more likely to work outside the home or be
students and less likely to be homemakers, retired,
unemployed or disabled. More women in the urban site
relied on their own wages or salary and fewer on their
partners’ income or other form of support or social
assistance. Analysis by site revealed no statistically
significant differences in the nondemographic risk
indicators and no difference in IPV rates; therefore,
subsequent inferential analyses were conducted on the
grouped sample.
Presence of risk indicators and relationship with
IPV status. Of the 768 women who provided informed
consent and were included in the sample, 40 women
(5.2%) did not provide sufficient data on the CAS to
allow a determination of their IPV status. These cases
were excluded from the regression analyses, leaving
728 cases for these analyses. CAS scores indicated that
13.9% (101/728) of these women reported being
exposed to IPV in the previous 12 months. Table 2
presents the percentage of women in the sample who
were positive for each risk indicator, stratified by IPV
status, and the bivariate associations between risk
indicators and reports of IPV. Since no significant
interactions between site and any indicator were found,
simple bivariate associations are presented. Those
women who reported IPV were significantly more likely
to be separated, living in a common-law relationship or
single, to have a male partner employed less than part
time, to have a partner with an alcohol or drug
problem, and to be experiencing depression or
somatization. They were also significantly younger, as
were their partners. Being pregnant was not
significantly associated with IPV status.
Table 3 presents the positive and negative
predictive values, sensitivity, specificity and efficiency
of the risk indicators as predictors of abuse status,
singly and in groups. Although the absence of
indicators is quite predictive of no abuse exposure (as
seen in the specificity values of > 90% and the negative
predictive values of > 86%), the sensitivity and positive
predictive values are low to moderate. Generally, the
questions are reasonably efficient in predicting abuse
status, although this is driven by the negative
predictive values.
Overall relationship between risk indicators and
IPV. In the full regression model (Table 4), with the
exception of marital status and the 2 age variables, all
indicators that were significantly related to IPV in the
bivariate analyses remained so. Each indicator was
associated with an OR of at least 4.0. Overall, the
model accounts for 22% of the variance in IPV status.
None of the hypothesized interaction effects was
significant.
Regarding the number of risk indicators, the
majority of women had no (40.1%) or 1 (38.3%)
indicator; 21.6% had 2 or more indicators; and 8.9%
had 3 or more. The number of risk indicators present
was significantly related to IPV status, with each unit
increase in number of indicators corresponding to a
nearly four-fold increase in IPV risk (OR = 3.92, 95%
CI 3.06–5.02, p < 0.001). Figure 1 shows the receiver
operating characteristic (ROC) curve describing the
predictive value of the number of risk indicators; the
area under the curve was 0.839 (95% CI 0.793–0.885,
p < 0.001).
Evaluation of risk indicator questions by
participants. Most women found the risk indicator
questions acceptable. The percentage of women who
indicated “not at all” to the items were as follows: hard
to understand, 93.4; make you feel uncomfortable,
87.7; make you feel upset, 89.5; make you feel angry,
93.4; embarrassing, 90.1; offensive, 95.5; too harsh,
95.3; too personal, 88.8.
Discussion
The present study took a clinically oriented approach
to examining the relationship between intimate partner
violence and the specific characteristics of women,Research Wathen et al
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their partners and their relationships to provide
information about the potential risk indicators for IPV
that are both clinically relevant and detectable during
history-taking and diagnostic assessment.
The annual prevalence rate of 13.9% in the present
study included all forms of abuse by an intimate
partner (physical, sexual and emotional/psychological),
and falls within the range of annual rates reported in
studies conducted in clinical samples in the United
States and Canada,
12,28,29 although the largest US study
using an ED sample measured only physical and sexual
abuse, finding a prevalence of 14.4%.
12 In addition, the
results regarding relationship and partner
characteristics are consistent with existing data,
including type of union
30,31 and the significant impact of
the male partner’s alcohol or drug abuse
30-36 and
underemployment.
33,36 Finally, the significant bivariate
association between both the woman’s age and IPV and
the partner’s age and IPV is consistent with previous
research,
12,30 women reporting IPV being significantly
younger and having younger partners. However, these
age variables, as well as the marital status variable,
were not significant in the multivariate model,
indicating that the significant bivariate relationships
result from the correlation of these variables with other
variables in the model. For example, younger women
are more likely to have younger partners. Younger
males are more likely to be aggressive and to perpetrate
more severe violence
30,37 and are more likely to be
underemployed.
38
In terms of specific characteristics of women and
their clinical utility in predicting IPV exposure, the 2
indicators of mental health are of particular interest.
Recent guidelines suggest that screening adults for
depression and linking the results to a diagnostic and
treatment plan are effective in reducing depression and
its health-related outcomes.
39,40 The present results and
those of others
5,6 suggest that the presence of
depression is an important risk indicator for IPV;
therefore, any woman with suspected depression
should be asked about IPV, as this could be a critical
factor in determining treatment options. Similarly, the
finding that 15% of the current sample scored “high” on
the questions concerning somatic symptoms is of note.
Of these women, 43% also reported IPV, a finding
consistent with that of Glass and colleagues,
41 who
found that 20% of women disclosing in the ED physical
or sexual abuse in the past year were presenting for
pain-related, non-injury complaints. This finding
suggests that women presenting with high levels of
somatic symptoms should be asked about exposure to
IPV; such inquiry has the potential to limit the need for
additional diagnostic investigations.
Of particular note is the additive effect of risk
indicators: for each additional indicator present, the
woman’s odds of reporting IPV in the past year
increased almost four-fold. More than 50% of the
women with 3 indicators reported IPV in the past year,
and this percentage approached 100% for women with
4–6 indicators, although the subsamples in the latter
group were small. The data on the predictive value of
multiple indicators provide further support for this
observation: the presence of 4 or more indicators
predicts abuse status with 96% accuracy.
The sole indicator that was not significantly
associated with abuse was pregnancy, a finding
consistent with the current literature. Although
unintended pregnancy has been linked to abuse,
42 most
studies find either no significant difference in rates of
abuse during the pre-, peri- and post-natal periods or a
trend toward a decrease in abuse when a woman is
pregnant.
43,44,45 Abuse that occurs earlier in the time
span between the pre- and post-natal periods (rather
than the pregnancy itself) is by far the strongest
predictor of abuse later in this time span; that is, pre-
natal abuse predicts peri- and post-natal abuse, andResearch Wathen et al
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peri-natal abuse predicts post-natal abuse.
44 The
potential consequences of abuse during pregnancy are,
however, severe,
46,47 and clinicians should maintain a
high degree of suspicion when pregnant women
present with clinical indicators of abuse.
There were demographic differences between the
two EDs from which participants were recruited, but
because these differences were consistent with the
urban versus semi-urban/rural characters of the 2
sites, the overall sample was representative of the
broader population.
48
Information not collected for this study, but that
should be considered for future research, included
whether the woman’s reason for presenting to the ED
(chief complaint) was directly related to IPV and
whether she was currently experiencing post-traumatic
stress disorder. These data would be useful to help
understand not only the relationships between and
among the current set of indicators, IPV and post-
traumatic stress disorder, but whether the visits to the
ED by women disclosing abuse was directly or
indirectly related to violence.
Clinical implications. In the absence of clear evidence
about whether routine screening for IPV does more
good than harm,
14,17,18 awareness by health care
providers of the types of indicators significantly
associated with IPV can assist with assessing and
responding appropriately to the patient (for example,
being sensitive to the need to interview a woman away
from any family members). Women in this study found
the risk indicator questions to be acceptable and did
not indicate concerns regarding being asked about
violence. The relatively poor performance of the
indicators as positive predictors of abuse, however,
precludes recommending that these be used as a form
of “risk-based screening”; rather, their utility lies in
signaling to the clinician that violence may be a
concern, especially when more than 1 risk indicator is
present. There may be some conditions (such as
depression) or symptoms (such as a high level of
somatic complaints) for which identifying IPV exposure
can assist with diagnosis and treatment. For example,
developing a treatment plan for depression that
includes antidepressants or cognitive behavior therapy
or both without taking into account exposure to
violence could reduce the effectiveness of the
management strategy. Ultimately, these findings might
serve as the basis for the derivation of a clinical
prediction rule to be used by ED staff in the
identification of IPV victims; however, additional
research is needed to determine the right combination
of indicators to ask about to improve the predictive
value of this approach. An important yet unanswered
question is, Once a woman is identified as a victim of
violence, how can clinicians best care for her? This
question remains a pressing research gap.
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